[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.147.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 8,228
Citations 0
Editorial
June 7, 2016

Who Should Be Screened for Lung Cancer? And Who Gets to Decide?

Author Affiliations
  • 1Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena
JAMA. 2016;315(21):2279-2281. doi:10.1001/jama.2016.5986

Screening for lung cancer has come of age at a time when traditional approaches to mass screening are being challenged.1 For some cancers, physicians are moving slowly from a paternalistic model in which screening is considered mandatory for any patient who belongs to a defined high-risk group, to a newer patient-centered model in which the decision to screen is individualized and informed by a detailed discussion of potential benefits and harms. Conversations about cancer screening increasingly occur in the context of personalized medicine, individualized risk assessment, and shared decision making.

First Page Preview View Large
First page PDF preview
First page PDF preview
×